Temasek-backed entity to acquire 16% stake in Ayala’s healthcare arm
Global investors are increasingly drawn to South-east Asia’s healthcare sector
[BENGALURU] AC Health, the healthcare arm of the Philippines’ oldest conglomerate Ayala, said on Monday (Aug 11) that a private equity firm backed by Singapore’s state-investor Temasek will acquire a 16 per cent minority stake in the company.
In August 2024, Reuters reported that Ayala was keen on selling a minority stake in its healthcare business, which would value the company at up to US$500 million.
AC Health did not specify a value for the 16 per cent stake.
Global investors are increasingly drawn to South-east Asia’s healthcare sector, wagering on the region’s rising prosperity, ageing demographics, and the industry’s resilience in a challenging economic climate.
In November 2023, Malaysian conglomerate Sime Darby and Australia’s Ramsay Health Care agreed to sell their equal ownership joint venture for RM5.7 billion (S$1.7 billion).
Established in 2015, AC Health has expanded its portfolio to include the Generika and St Joseph Drug pharmacy chains, as well as pharmaceutical importer and distributor IE Medica and MedEthix, according to its websites.
SEE ALSO
It aims to expand its network to at least 10 hospitals, 300 clinics and 1,150 pharmacies. REUTERS
Share with us your feedback on BT's products and services
